Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021

The Delta variant has become the dominant strain of SARS-CoV-2. We summarised the evidence on COVID-19 vaccine effectiveness (VE) identified in 17 studies that investigated VE against different endpoints. Pooled VE was 63.1% (95% confidence interval (CI): 40.9–76.9) against asymptomatic infection, 7...

Descripción completa

Detalles Bibliográficos
Autores principales: Harder, Thomas, Külper-Schiek, Wiebe, Reda, Sarah, Treskova-Schwarzbach, Marina, Koch, Judith, Vygen-Bonnet, Sabine, Wichmann, Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518304/
https://www.ncbi.nlm.nih.gov/pubmed/34651577
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.41.2100920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518304/
https://www.ncbi.nlm.nih.gov/pubmed/34651577
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.41.2100920

Ejemplares similares